This online abstract submission will close on June 2^nd, 2026 (11:59 p.m. Pacific Time USA). No late abstracts will be accepted. Presenting authors will be notified of the Scientific Committee's decision regarding acceptance of their abstracts by June 19, 2025.

1) Access your personal depositary space:

- If you already have an account, enter your login below;

- If you do not have an account yet, click on "create your depositary space"

2) Choose "New abstract".

3)  Enter your abstract title and select from the scroll-down menu:

- Type of presentation (In-Person Symposium, In-Person Oral Communication, Poster presentations). If your abstract is selected, the Scientific Committee will decide on the type of presentation. Do not submit twice in two different categories. Only poster presentations can be presented remotely. 

- Topics (for Oral Communication and Poster Presentations only) 

• 1.Clinical Trials – Phase IIb & III - Late-stage interventional studies evaluating efficacy and safety. 

• 2.Clinical Trials – Phase I & IIa - Early-phase studies focused on safety, tolerability, and preliminary efficacy. 

• 3.Non-pharmacologic interventions - Lifestyle, behavioral, and combined intervention strategies. 

• 4.Imaging (MRI & PET) - Structural and functional neuroimaging studies. 

• 5.Biomarkers (CSF & Plasma) - Fluid biomarkers for diagnosis, prognosis, and therapeutic monitoring. 

• 6.Artificial Intelligence - Machine learning, predictive modeling, and computational tools. 

• 7.Epidemiology - Population-based studies and risk factor analysis. 

• 8.Pre-clinical, Early Discovery and Mechanistic Research - Mechanistic research and therapeutic development in model systems. 

• 9. Trial design, Statistical innovation, and Analytical frameworks - Advancing clinical research through innovative trial design, statistical methods, and analytical strategies. 

• 10.Cognitive and Functional Outcomes - Measuring cognitive performance and real-world function to better assess clinical outcomes 

• 11.Digital endpoints, Remote Monitoring, and Connected Health Tools - Leveraging digital technologies to capture real-world, continuous health data 

• 12.Miscellaneous - Emerging topics not covered in the above categories. 

• 13.Biotech Showcase - Company-led scientific and development presentations. 

   

It is the author's responsibility to submit a structured abstract according to the instructions to authors. Abstracts not respecting the format, with language editing required or no data will be automatically discarded.  

4) Write the name of the presenting author (Last name, first name, email, affiliation, [in the 'Affiliation' field, please indicate your hospital, company name], City, Country). The affiliation's number will be "1" and tick the box "Speaker". The information relative to the abstract will be sent to the presenting author. Click on "New Co-Author" if you want to add co-authors (15 max). You must have obtained prior authorization from your co-authors. 

Acknowledgement of the receipt of abstract submission will be sent to the Presenting Author's email address immediately upon submission. In addition, all communications regarding abstract acceptance and presentation will be sent to the Presenting Author's email.

5) Please click on this link and carefully read the Abstract Guidelines before submitting an abstract. Abstracts can only be submitted electronically through this web page. Abstracts not abiding by the guidelines will be rejected.

6) You can now preview and save your abstract, you have the option of modifying it before validation.

7) To submit your abstract, please click on "Submission", from this moment on, you will not be able to make any changes in your depositary space.